Eton Pharmaceuticals (ETON) Treasury Shares (2017 - 2024)
Eton Pharmaceuticals (ETON) reported Treasury Shares of $226068.0 for Q4 2024, down 17.55% on a YoY basis from $274204.0 in Q1 2024, and down 17.55% sequentially from $274204.0 in Q4 2023.
Eton Pharmaceuticals (ETON) Treasury Shares (2017 - 2024) Analysis & Trends
Eton Pharmaceuticals (ETON) has 6 years of Treasury Shares data on file, last reported at $226068.0 in Q4 2024.
- For the quarter ending Q4 2024, Treasury Shares fell 17.55% year-over-year to $226068.0; the trailing twelve-month figure through Dec 2024 stood at $226068.0 (down 17.55% YoY), and the FY2024 full-year result was $226068.0, down 17.55% from the prior year.
- Treasury Shares fell to $226068.0 in Q4 2024, from $274204.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $369606.0 in Q3 2022 to a low of $7595.0 in Q4 2020.
- A 4-year average of $249415.8 and a median of $274204.0 in 2023 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares retreated 25.81% in 2023 and decreased 17.55% in 2024, its largest moves.
- Tracing ETON's Treasury Shares over 4 years: stood at $7595.0 in 2020, then soared by 4766.44% to $369606.0 in 2022, then dropped by 25.81% to $274204.0 in 2023, then decreased by 17.55% to $226068.0 in 2024.
- Business Quant data shows ETON's Treasury Shares at $226068.0 in Q4 2024, $274204.0 in Q4 2023, and $369606.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 226,068.00 |
| Dec 31, 2024 | 226,068.00 |
| Dec 31, 2023 | 274,204.00 |
| Dec 31, 2023 | 274,204.00 |
| Dec 31, 2022 | 369,606.00 |
| Dec 31, 2022 | 369,606.00 |
| Sep 30, 2022 | 369,606.00 |
| Sep 30, 2022 | 369,606.00 |
| Dec 31, 2020 | 7,595.00 |
| Dec 31, 2020 | 7,595.00 |
| Dec 31, 2018 | 312,500.00 |
| Dec 31, 2018 | 312,500.00 |
| Sep 30, 2018 | 6.69 Mn |
| Sep 30, 2018 | 6.69 Mn |
| Jun 30, 2018 | 6.69 Mn |
| Jun 30, 2018 | 6.69 Mn |
| Mar 31, 2018 | 6.69 Mn |
| Mar 31, 2018 | 6.69 Mn |
| Dec 31, 2017 | 6.69 Mn |
| Dec 31, 2017 | 6.69 Mn |